| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5618472 | Journal of Vascular Surgery | 2017 | 8 Pages |
Abstract
Sarcopenia is a risk factor for worse cardiovascular event-free survival, and SAPT and statin therapy reduced this risk for patients with CLI. Furthermore, SAPT but not dual antiplatelet therapy increased cardiovascular event-free survival in patients with sarcopenia.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Yutaka MD, Takuya MD, PhD, Kentaro MD, Daisuke MD, Ryosuke MD, Keiji MD, Tadashi MD, PhD, Yoshihiko MD, PhD,